Pescosolido, B. A., Martin, J. K., Long, J. S., Medina, T. R., Phelan, J. C., & Link, B. G. (2010). "A
disease like any other"? A decade of change in public reactions to schizophrenia, depression, and
alcohol dependence. American Journal of Psychiatry, 167(11), 1321-1330.
Peter D. Hart Research Associates. (2001). The face of recovery. Survey among the recovery community
conducted August 2-22, 2001 for The Alliance Project. [Power Point Presenation].
Peter D.Hart Research Associates, & Peter. (2001). The face of recovery. [Online]. Retrieved October 28,
2005 from http://www.facesandvoicesofrecovery.org.
Peters, R. H., & Matthews, C. O. (2003). Substance abuse treatment programs in prisons and jails. In T. J.
Fagan & R. K. Ax (Eds.), Correctional mental health handbook (pp. 73-74). Thousand Oaks, CA:
Sage.
Peters, R. H., Bartoi, M. G., & Sherman, P. B. (2008). Screening and assessment of co-occurring
disorders in the justice system. New York: CMHS National GAINS Center.
Peters, R. H., Greenbaum, P. E., Steinberg, M. L., Carter, C. R., Ortiz, M. M., Fry, B. C., et al. (2000).
Effectiveness of screening instruments in detecting substance use disorders among prisoners. Journal
of Substance Abuse Treatment, 18(4), 349-358.
Peterson, A. V., Jr., Kealey, K. A., Mann, S. L., Marek, P. M., Ludman, E. J., Liu, J., et al. (2009).
Group-randomized trial of a proactive, personalized telephone counseling intervention for adolescent
smoking cessation. Journal of the National Cancer Institute, 101(20), 1378-1392.
Peterson, M., & Johnstone, B. M. (1995). The Atwood Hall Health Promotion Program, Federal Medical
Center, Lexington, KY. Effects on drug-involved federal offenders. Journal of Substance Abuse
Treatment, 12(1), 43-48.
Petrakis, I. L., Leslie, D., & Rosenheck, R. (2003). Use of naltrexone in the treatment of alcoholism
nationally in the Department of Veterans Affairs. Alcoholism: Clinical & Experimental Research,
27 (11), 1780-1784.
Petrakis, I. L., Rosenheck, R., & Desai, R. (2011). Substance use comorbidity among veterans with
posttraumatic stress disorder and other psychiatric illness. American Journal on Addictions, 20(3),
185-189.
Petrone, K., & Katz, P. (2005). Approaches to appropriate drug prescribing for the older adult. Primary
Care Clinical Office Practice, 32(3), 755-775.
Petry, N. M., Peirce, J. M., Stitzer, M. L., Blaine, J., Roll, J. M., Cohen, A., et al. (2005). Effect of prize-
based incentives on outcomes in stimulant abusers in outpatient psychosocial treatment programs: A
national drug abuse treatment clinical trials network study. Archives of General Psychiatry, 62(10),
1148-1156.
Pettinati, H. M., Kampman, K. M., Lynch, K. G., Suh, J. J., Dackis, C. A., Oslin, D. W., et al. (2008).
Gender differences with high-dose naltrexone in patients with co-occurring cocaine and alcohol
dependence. Journal of Substance Abuse Treatment, 34(4), 378-390.
Petursson, H. (1994). The benzodiazepine withdrawal syndrome. Addiction, 89(11), 1455-1459.
Physicians and Lawyers for National Drug Policy. (2008). Screening, brief intervention, referral, and
treatment (SBIRT) of acute care patients for alcohol use disorders. [Online]. Retrieved October 8,
2008 from http://www.plndp.org.
Pierce, J. P., & Gilpin, E. A. (1995). A historical analysis of tobacco marketing and the uptake of
smoking by youth in the United States: 1890-1977. Health Psychology, 14(6), 500-508.